Moneycontrol PRO
Loans
Loans
HomeNewsDivis

Divis

Jump to
  • Top Nifty gainers and losers: Cipla and Divi's gain, HCL, TCS sink

    About 1734 shares advanced, 1817 shares declined, and 133 shares unchanged.

  • Divi's Lab declines 5% amid concern over 'unsustainable' growth  

    Divi's Lab net profit increased by 78 per cent to Rs 895 crore in the March quarter against Rs 502 crore a year ago. Revenue from operations rose 40% to Rs 2,518 crore as against Rs 1,788 crore in the year-ago period.

  • Ideas For Profit | What the second covid-19 ‘wave’ means for domestic pharma companies?

    With the second Covid ‘Wave’ already surpassing the daily highs recorded in the month of September 2020 of about 95000, the demand for vaccines, critical medical equipment like vaccines, oxygen cylinders and ventilators have increased manifold. Watch the video to know what this evolving situation means for Indian Pharma?

  • Divis Q4 PAT seen up 41.1% YoY to Rs. 467.2 cr: Sharekhan

    Net Sales are expected to increase by 20.9 percent Y-o-Y (down 1.3 percent Q-o-Q) to Rs. 1,680 crore, according to Sharekhan.

  • Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay

    Net Sales are expected to increase by 5.4 percent Y-o-Y (up 16.5 percent Q-o-Q) to Rs. 1,354.7 crore, according to Emkay.

  • Divis Q3 PAT seen up 53.5% YoY to Rs. 370 cr: Sharekhan

    Net Sales are expected to increase by 25 percent Y-o-Y (up 1 percent Q-o-Q) to Rs. 1,297.4 crore, according to Sharekhan.

  • Divis Q2 PAT seen up 39.2% YoY to Rs. 272.5 cr: Sharekhan

    Net Sales are expected to increase by 20 percent Y-o-Y (up 7.3 percent Q-o-Q) to Rs. 1,068.2 crore, according to Sharekhan.

  • How the US regulator's import ban has pushed Divis off its pedestal

    The company that earlier maintained a clean regulatory track record failed spectacularly in the US FDA's audit last December.

  • Tax woes spook market; Sensex & Nifty erase 2016 gains

    Markets slipped in trade today erasing all the gains made so far in 2016. The Nifty is now negative for 2016 erasing all gains made so far this year and also ending at its lowest level in 2016. Midcaps got battered in trade.

  • Stocks in news: ACC, UltraTech, MCX, IOC, Jet, KEC, Tata Power

    ACC | Ambuja Cement | India Cements | IOC | MCX | Ramco Cements | UltraTech Cement | Jaiprakash Associates | JK Cements | Tata Power | KEC International | Uniply Industries | C&C Constructions | Praj Industries | Esab India and Indo Rama Synthetics are stocks, which are in the news today.

  • Q3 earnings: Nirmal Bang reviews Glenmark, Divi's results

    In an interview to CNBC-TV18, Praful Borah of Nirmal Bang Institutional Equities speak about Glenmark, Divi's results and gives his outlook going forward.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347